We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$2.21B
AUM Growth
+$402M
(+22%)
Cap. Flow
+$267M
Cap. Flow
% of AUM
12.07%
Top 10 Holdings %
Top 10 Hldgs %
16.09%
Holding
1,247
New
172
Increased
894
Reduced
64
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.97M |
| 2 |
Apple
AAPL
|
+$8.92M |
| 3 |
Amazon
AMZN
|
+$8.89M |
| 4 |
Broadcom
AVGO
|
+$8.06M |
| 5 |
BF
BASF AKTIENGESELLT ADS(RP1 ORD
BF
|
+$7.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$3.45M |
| 2 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$3.39M |
| 3 |
MSCI
MSCI
|
+$3.27M |
| 4 |
Broadridge
BR
|
+$3.02M |
| 5 |
MON
Monsanto Co
MON
|
+$2.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 12.6% |
| 3 | Healthcare | 11.99% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Jabil
JBL
$32.8B
| $1.5M | 0.07% |
54,290
+5,794
| +12% | +$163K |
|
377
Viatris
VTRS
$20.1B
| $1.5M | 0.07% |
+41,452
| New | +$1.63M |
|
378
Cardinal Health
CAH
$53.4B
| $1.5M | 0.07% |
30,680
+5,889
| +24% | +$334K |
|
379
Olin
OLN
$2.64B
| $1.49M | 0.07% |
51,801
+5,556
| +12% | +$173K |
|
|
SVC
380
Service Properties Trust
SVC
$1.1B
| $1.49M | 0.07% |
10,397
+1,526
| +17% | +$206K |
|
381
Haemonetics
HAE
$3.58B
| $1.48M | 0.07% |
+16,510
| New | +$1.39M |
|
382
Prosperity Bancshares
PB
$8.77B
| $1.48M | 0.07% |
21,650
+2,325
| +12% | +$170K |
|
|
MDSO
383
DELISTED
Medidata Solutions, Inc.
MDSO
| $1.48M | 0.07% |
18,362
+1,968
| +12% | +$148K |
|
384
Bread Financial
BFH
$4.21B
| $1.48M | 0.07% |
7,939
+2,656
| +50% | +$454K |
|
|
CHK
385
DELISTED
Chesapeake Energy Corporation
CHK
| $1.48M | 0.07% |
1,409
+151
| +12% | +$117K |
|
|
PXD
386
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.48M | 0.07% |
7,798
+1,364
| +21% | +$261K |
|
|
PRAH
387
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.47M | 0.07% |
+15,782
| New | +$1.36M |
|
388
Estee Lauder
EL
$29B
| $1.47M | 0.07% |
10,319
+1,736
| +20% | +$257K |
|
389
Molina Healthcare
MOH
$10.3B
| $1.47M | 0.07% |
15,023
+2,295
| +18% | +$200K |
|
390
Idacorp
IDA
$8.23B
| $1.47M | 0.07% |
15,941
+2,287
| +17% | +$205K |
|
391
Idexx Laboratories
IDXX
$42.9B
| $1.46M | 0.07% |
6,720
+1,142
| +20% | +$235K |
|
392
TE Connectivity
TEL
$58.8B
| $1.46M | 0.07% |
+16,260
| New | +$1.56M |
|
393
NetApp
NTAP
$32.9B
| $1.46M | 0.07% |
18,607
+3,175
| +21% | +$223K |
|
394
Associated Banc-Corp
ASB
$5.81B
| $1.46M | 0.07% |
53,488
+7,415
| +16% | +$199K |
|
395
Landstar System
LSTR
$6.8B
| $1.45M | 0.07% |
13,305
+1,905
| +17% | +$209K |
|
|
STI
396
DELISTED
SunTrust Banks, Inc.
STI
| $1.45M | 0.07% |
21,977
+1,733
| +9% | +$118K |
|
397
Edwards Lifesciences
EW
$47.6B
| $1.45M | 0.07% |
29,838
+6,336
| +27% | +$296K |
|
398
ITT
ITT
$17.5B
| $1.45M | 0.07% |
27,643
+3,838
| +16% | +$200K |
|
|
WGL
399
DELISTED
Wgl Holdings
WGL
| $1.44M | 0.07% |
16,248
+2,351
| +17% | +$205K |
|
400
National Fuel Gas
NFG
$7.84B
| $1.44M | 0.07% |
27,180
+4,045
| +17% | +$210K |
|
Similar funds
SAM
Pacer Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Pacer Advisors held 1,247 positions worth $2.21B, up 22% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Pacer Advisors deployed $267M of net new capital in Q2 2018, opening 172 new positions and adding to 894 existing holdings. Its largest new stake was Broadcom: 328,700 shares worth $7.98M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Abiomed Inc, an estimated $3.45M trimmed.
- Pacer Advisors's largest Q2 2018 buy was Broadcom: 328,700 shares worth $7.98M.
- Pacer Advisors added most to Microsoft in Q2 2018, an estimated $8.97M increase.
- Pacer Advisors's biggest Q2 2018 reduction was Abiomed Inc, cutting an estimated $3.45M.
- Pacer Advisors fully exited Royal Dutch Shell PLC ADS Class B in Q2 2018, selling an estimated $3.39M.
- Pacer Advisors's ten largest holdings make up 16% of its $2.21B portfolio in Q2 2018.
- Pacer Advisors opened 172 new positions and closed 79 in Q2 2018.
- Pacer Advisors's portfolio value rose 22% quarter-over-quarter to $2.21B.
Based on Pacer Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.